COVID-19 has created challenges for society and the medical community.
While the pandemic continues to unfold, the transplant community has had
to pivot to keep recipients, donors, and transplant teams safe given
these unprecedented times. This has resulted in a decrease in the number
of transplants performed in the United States and an increased number of
inactive patients on the UNOS waiting list.1 Waitlist and transplant
recipients have an increased risk for acquiring COVID-19. It is
speculated that this patient population is particularly vulnerable given
their immunocompromised status and the high prevalence of
comorbidities.2 Given the uncertainty surrounding the risk of transplant
patients contracting COVID-19, there is interest in describing these
cases in the literature.